These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15363004)

  • 1. Clinical phenotypes of COPD: results of a Japanese epidemiological survey.
    Tatsumi K; Kasahara Y; Kurosu K; Tanabe N; Takiguchi Y; Kuriyama T;
    Respirology; 2004 Aug; 9(3):331-6. PubMed ID: 15363004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD in Japan: the Nippon COPD Epidemiology study.
    Fukuchi Y; Nishimura M; Ichinose M; Adachi M; Nagai A; Kuriyama T; Takahashi K; Nishimura K; Ishioka S; Aizawa H; Zaher C
    Respirology; 2004 Nov; 9(4):458-65. PubMed ID: 15612956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a predominant COPD phenotype in clinical practice.
    Pistolesi M; Camiciottoli G; Paoletti M; Marmai C; Lavorini F; Meoni E; Marchesi C; Giuntini C
    Respir Med; 2008 Mar; 102(3):367-76. PubMed ID: 18248806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of airway dimensions in different anatomic locations on chest CT in patients with COPD.
    Ohara T; Hirai T; Sato S; Sato A; Nishioka M; Muro S; Mishima M
    Respirology; 2006 Sep; 11(5):579-85. PubMed ID: 16916330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
    Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
    Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor sensitivity of symptoms in early detection of COPD.
    Akamatsu K; Yamagata T; Kida Y; Tanaka H; Ueda H; Ichinose M
    COPD; 2008 Oct; 5(5):269-73. PubMed ID: 18972274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index in male patients with COPD: correlation with low attenuation areas on CT.
    Ogawa E; Nakano Y; Ohara T; Muro S; Hirai T; Sato S; Sakai H; Tsukino M; Kinose D; Nishioka M; Niimi A; Chin K; Paré PD; Mishima M
    Thorax; 2009 Jan; 64(1):20-5. PubMed ID: 18852156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
    Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
    Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
    Kałucka S
    Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease in patients admitted with heart failure.
    Iversen KK; Kjaergaard J; Akkan D; Kober L; Torp-Pedersen C; Hassager C; Vestbo J; Kjoller E;
    J Intern Med; 2008 Oct; 264(4):361-9. PubMed ID: 18537871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.
    Makita H; Nasuhara Y; Nagai K; Ito Y; Hasegawa M; Betsuyaku T; Onodera Y; Hizawa N; Nishimura M;
    Thorax; 2007 Nov; 62(11):932-7. PubMed ID: 17573447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
    Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
    Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The rate of airflow limitation among the elderly undergoing spirometry in a university hospital].
    Tojo N; Umino T; Miyasaka N
    Rinsho Byori; 2004 Aug; 52(8):649-54. PubMed ID: 15478620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.